AMGEN USA INC.
UEI XPGNQMXHP493 · Federal customer, award and market-category activity · All available history.Registered entity address in historical award records
Vendor entity location
This is the vendor entity address recorded on its latest historical award action. It is separate from contract place-of-performance geography.
Street address
1 AMGEN CENTER DRCity
THOUSAND OAKSState or territory
CALIFORNIAZIP code
913201730Country
UNITED STATESCongressional district
26All available history
Net obligations by year
2012
2013
2016
2017
2018
2021
2022
2023
2024
2025
2026
Corporate family from historical award records
1 total
Related entities
Connected through ultimate parent AMGEN USA INC (UEI Y6NEW42XK544). Only entities present in historical award records are included.
| Rank | Entity | UEI | Primary CAGE | CAGE codes | Obligations | Actions | Activity |
|---|---|---|---|---|---|---|---|
| 1 | AMGEN USA INC. | XPGNQMXHP493 | 5YNZ4 | 1 | $345.71M | 11 | 2024–2026 |
Customer concentration
3 totalBuying agencies
| Rank | Agency | Code | Obligations | Actions | Share |
|---|---|---|---|---|---|
| 1 | OFFICE OF ASSISTANT SECRETARY FOR ADMINISTRATION AND MANAGEMENT | 7505 | $1.03B | 25 | 100.0% |
| 2 | VETERANS AFFAIRS, DEPARTMENT OF | 3600 | $369.9K | 5 | 0.0% |
| 3 | FEDERAL PRISON SYSTEM / BUREAU OF PRISONS | 1540 | $13.4K | 3 | 0.0% |
Entity locations
1 foundCAGE codes associated with this UEI
| CAGE | Recorded name | First seen | Last seen | Obligations | Actions |
|---|---|---|---|---|---|
| 5YNZ4 | AMGEN USA INC. | Jun 14, 2017 | Aug 4, 2026 | $995.93M | 27 |
Market categories
3 totalNAICS industries
| Rank | NAICS | Description | Obligations | Actions | Share |
|---|---|---|---|---|---|
| 1 | 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $840.69M | 12 | 81.3% |
| 2 | 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | $192.76M | 13 | 18.6% |
| 3 | 325412 | PHARMACEUTICAL PREPARATION MANUFACTURING | $383.3K | 8 | 0.0% |
Market categories
2 totalProduct & service codes
| Rank | PSC | Description | Obligations | Actions | Share |
|---|---|---|---|---|---|
| 1 | AN13 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | $879.01M | 23 | 85.0% |
| 2 | 6505 | DRUGS AND BIOLOGICALS | $154.83M | 10 | 15.0% |
Latest activity
12 total
